Ameriprise Financial Inc Abcam PLC Transaction History

Ameriprise Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $77.1 Million - $87.3 Million	-3,577,671 Reduced 72.19%	1,377,940 $31.2 Million
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $8.05 Million - $15.6 Million	637,679 Added 14.77%	4,955,611 $121 Million
Q1 2023 May 15, 2023	SELL	$12.98 - $17.1 $9.04 Million - $11.9 Million	-696,446 Reduced 13.89%	4,317,932 $58.1 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $69.8 Million - $85.2 Million	5,014,378 New	5,014,378 $78 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.